Reading ATRC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ATRC free→Reading ATRC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ATRC free→QuarterlyIQ Insights · ATRC
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 2 valuation methods, at three horizons. Current price $28.79. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Peer P/FCF | 12M | $27.87 | 29.2 | 0.96 | TTM | high |
| Peer P/S | 12M | $29.10 | 2.7 | 10.80 | TTM | high |
| Peer P/S | 3Y | $46.99 | 2.7 | 17.44 | Analyst | medium |
| Peer P/S | 5Y | $64.67 | 2.7 | 24.00 | Analyst | medium |
Monthly trailing P/E with quartile reference lines.
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.